. Author manuscript; available in PMC: 2016 Jan 31.

Published in final edited form as: Brain Behav Immun. 2014 Sep 8;44:91–99. doi: 10.1016/j.bbi.2014.08.010

Table 1. CD4 expression levels in the spinal cord do not change during CIPN.

No significant changes were detected in the expression levels of CD4 within the dorsal spinal cord of oxaliplatin-treated rats at a time-point of peak mechano-hypersensitivity (D25). Results are analyzed by Student’s t-test (Ct) and expressed as fold change as compared to vehicle for n=5 rats/group.

Group	Gene	Ct (Mean ± SD)	n-value	Fold-change
Vehicle	CD4	24.4 ± 2.09	5
	HPRT1	19.3 ± 0.200
Oxaliplatin	CD4	23.9 ± 1.24	5	0.693
	HPRT1	19.1 ± 0.190